Michael Kyriakides

Michael Kyriakides

Partner

Michael Kyriakides is a Partner of Syncona Investment Management Ltd.

He works closely with Syncona portfolio companies Freeline Therapeutics, Gyroscope Therapeutics and Clade Therapeutics. 

Previously, Michael was a member of the Life Sciences team at L.E.K. Consulting, where he worked in projects for pharmaceutical, biotech and private equity clients. Prior to joining L.E.K. Consulting, he was a clinical project and NMR manager in the Faculty of Medicine at Imperial College London. Michael obtained his doctorate degree in toxicology and metabolic profiling at Imperial College London.

Syncona portfolio companies

  • Freeline Therapeutics
  • Gyroscope Therapeutics
  • Clade Therapeutics (Board observer)
Martin Murphy

Martin Murphy

Chief Executive Officer
Chris Hollowood

Chris Hollowood

Chief Investment Officer
Markus John

Markus John

Chief Medical Officer and Head of R&D
Elisa Petris

Elisa Petris

Partner
Alice Renard

Alice Renard

Partner